BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 25448790)

  • 1. Polymyositis/dermatomyositis and malignancy risk: a metaanalysis study.
    Yang Z; Lin F; Qin B; Liang Y; Zhong R
    J Rheumatol; 2015 Feb; 42(2):282-91. PubMed ID: 25448790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The overall and temporal association of cancer with polymyositis and dermatomyositis.
    Zantos D; Zhang Y; Felson D
    J Rheumatol; 1994 Oct; 21(10):1855-9. PubMed ID: 7837150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idiopathic inflammatory myopathy associated with malignancy: a retrospective cohort of 151 Korean patients with dermatomyositis and polymyositis.
    So MW; Koo BS; Kim YG; Lee CK; Yoo B
    J Rheumatol; 2011 Nov; 38(11):2432-5. PubMed ID: 21844145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of Malignancy in Dermatomyositis and Polymyositis.
    Qiang JK; Kim WB; Baibergenova A; Alhusayen R
    J Cutan Med Surg; 2017; 21(2):131-136. PubMed ID: 27534779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis of the association of dermatomyositis and polymyositis with cancer.
    Wang J; Guo G; Chen G; Wu B; Lu L; Bao L
    Br J Dermatol; 2013 Oct; 169(4):838-47. PubMed ID: 23909921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematological malignancy associated with polymyositis and dermatomyositis.
    Marie I; Guillevin L; Menard JF; Hatron PY; Cherin P; Amoura Z; Cacoub P; Bachelez H; Buzyn A; Le Roux G; Ziza JM; Brice P; Munck JN; Sarrot-Reynauld F; Piette JC; Larroche C
    Autoimmun Rev; 2012 Jul; 11(9):615-20. PubMed ID: 22079677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottish population-based cohort study.
    Stockton D; Doherty VR; Brewster DH
    Br J Cancer; 2001 Jul; 85(1):41-5. PubMed ID: 11437400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignancies associated with dermatomyositis and polymyositis in Taiwan: a nationwide population-based study.
    Huang YL; Chen YJ; Lin MW; Wu CY; Liu PC; Chen TJ; Chen YC; Jih JS; Chen CC; Lee DD; Chang YT; Wang WJ; Liu HN
    Br J Dermatol; 2009 Oct; 161(4):854-60. PubMed ID: 19558555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated cancer incidence in patients with dermatomyositis: a population based study.
    Airio A; Pukkala E; Isomäki H
    J Rheumatol; 1995 Jul; 22(7):1300-3. PubMed ID: 7562762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer risk following polymyositis and dermatomyositis: a nationwide cohort study in Denmark.
    Chow WH; Gridley G; Mellemkjaer L; McLaughlin JK; Olsen JH; Fraumeni JF
    Cancer Causes Control; 1995 Jan; 6(1):9-13. PubMed ID: 7718740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of cancer to inflammatory muscle diseases. Dermatomyositis, polymyositis, and inclusion body myositis.
    Callen JP
    Rheum Dis Clin North Am; 1994 Nov; 20(4):943-53. PubMed ID: 7855330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High incidence of malignancies in patients with dermatomyositis and polymyositis: an 11-year analysis.
    Maoz CR; Langevitz P; Livneh A; Blumstein Z; Sadeh M; Bank I; Gur H; Ehrenfeld M
    Semin Arthritis Rheum; 1998 Apr; 27(5):319-24. PubMed ID: 9572713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and predictive factors for malignancies in 136 Japanese patients with dermatomyositis, polymyositis and clinically amyopathic dermatomyositis.
    Azuma K; Yamada H; Ohkubo M; Yamasaki Y; Yamasaki M; Mizushima M; Ozaki S
    Mod Rheumatol; 2011 Apr; 21(2):178-83. PubMed ID: 20922453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence, cancer risk and mortality of dermatomyositis and polymyositis in Taiwan: a nationwide population study.
    Kuo CF; See LC; Yu KH; Chou IJ; Chang HC; Chiou MJ; Luo SF
    Br J Dermatol; 2011 Dec; 165(6):1273-9. PubMed ID: 21895620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors Associated with Interstitial Lung Disease in Patients with Polymyositis and Dermatomyositis: A Systematic Review and Meta-Analysis.
    Zhang L; Wu G; Gao D; Liu G; Pan L; Ni L; Li Z; Wang Q
    PLoS One; 2016; 11(5):e0155381. PubMed ID: 27171228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive factors and unfavourable prognostic factors of interstitial lung disease in patients with polymyositis or dermatomyositis: a retrospective study.
    Ji SY; Zeng FQ; Guo Q; Tan GZ; Tang HF; Luo YJ; Tang ZQ; Han YF
    Chin Med J (Engl); 2010 Mar; 123(5):517-22. PubMed ID: 20367973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical analysis of pneumomediastinum complicated in polymyositis and dermatomyositis].
    Tong SQ; Shi XH; Su JM; Zhao Y; Zhang FC
    Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(9):624-7. PubMed ID: 16681909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased osteoporosis risk in dermatomyositis or polymyositis independent of the treatments: a population-based cohort study with propensity score.
    Lee CW; Muo CH; Liang JA; Sung FC; Hsu CY; Kao CH
    Endocrine; 2016 Apr; 52(1):86-92. PubMed ID: 26429781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dermatomyositis and ovarian cancer: a report of 7 cases and literature review.
    Cherin P; Piette JC; Herson S; Bletry O; Wechsler B; Frances C; Godeau P
    J Rheumatol; 1993 Nov; 20(11):1897-9. PubMed ID: 8308775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignancy in dermatomyositis and polymyositis: analysis of 192 patients.
    Fang YF; Wu YJ; Kuo CF; Luo SF; Yu KH
    Clin Rheumatol; 2016 Aug; 35(8):1977-1984. PubMed ID: 27210465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.